Unicycive Therapeutics, Inc. (UNCY)
5.34
-0.29
(-5.15%)
USD |
NASDAQ |
Aug 24, 16:00
5.35
+0.01
(+0.19%)
After-Hours: 20:00
Unicycive Therapeutics Total Assets (Quarterly) : 72.03M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 72.03M |
| March 31, 2026 | 64.41M |
| December 31, 2025 | 49.14M |
| September 30, 2025 | 50.61M |
| June 30, 2025 | 30.00M |
| March 31, 2025 | 27.95M |
| December 31, 2024 | 31.67M |
| September 30, 2024 | 38.57M |
| June 30, 2024 | 44.70M |
| March 31, 2024 | 52.38M |
| December 31, 2023 | 14.19M |
| September 30, 2023 | 19.44M |
| June 30, 2023 | 22.88M |
| March 31, 2023 | 27.20M |
| Date | Value |
|---|---|
| December 31, 2022 | 2.818M |
| September 30, 2022 | 10.18M |
| June 30, 2022 | 12.82M |
| March 31, 2022 | 15.76M |
| December 31, 2021 | 18.74M |
| September 30, 2021 | 19.78M |
| June 30, 2021 | 0.913M |
| March 31, 2021 | 0.513M |
| December 31, 2020 | 0.204M |
| September 30, 2020 | 0.219M |
| June 30, 2020 | 0.028M |
| March 31, 2020 | |
| December 31, 2019 | 0.019M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 285.13M |
| Theriva Biologics, Inc. | 34.86M |
| AbbVie, Inc. | 135.12B |
| Decoy Therapeutics, Inc. | 9.001M |
| Nkarta, Inc. | 337.64M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.76M |
| Shareholders Equity (Quarterly) | 53.27M |
| Debt to Equity Ratio | 0.0139 |
| Current Ratio | 3.813 |
| Net Debt Paydown Yield | -0.03% |